Share on twitter Share on linkedin WALTHAM, Mass.–(BUSINESS WIRE)–GelSight, a pioneer in tactile intelligence technology, announced today that it has been selected as a winner in Fast Company’s Next Big

Results presented on a predictive signature capable of identifying non-small cell lung cancer patients that will benefit most from immune checkpoint inhibitors.

Results on the application of its perspectIV™ platform in COVID-19 patients demonstrate that glycoproteomic profiles in patients with a severe course of the infection are significantly different from those who experienced an asymptomatic course of the infection.

Gary Hall joins 6K as Chief Financial Officer with over 20 years of experience leading finance and operational teams at high-growth, technology companies and helping these companies generate significant shareholder value through public and private offerings.

Share on twitter Share on linkedin NORTH ANDOVER, Mass., Sept. 28, 2021 /PRNewswire/ — 6K, an innovative leader in the production of sustainable advanced materials for energy storage and additive

LAUSANNE, Switzerland & FRAMINGHAM, Mass.–(BUSINESS WIRE)–Galderma, the world’s largest independent dermatology company, and Sofregen Medical, Inc., a medical device company pioneering the use of silk protein for tissue building and

Share on twitter Share on linkedin MENLO PARK, Calif. and BILLERICA, Mass., Sept. 23, 2021 /PRNewswire/ — Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced

Share on twitter Share on linkedin CAMBRIDGE, Mass.–(BUSINESS WIRE)–Adaptive Surface Technologies, Inc. (AST), a world leader in repellent surfaces, today announced it has entered into a new distribution partnership with

Share on twitter Share on linkedin North Andover, MA. Sept 22, 2021 – 6K, a leader in the production of sustainable advanced materials for energy storage and additive manufacturing powders,

Share on twitter Share on linkedin SAN DIEGO, Calif., Sept. 16, 2021 /PRNewswire/ — NanoCellect Biomedical Inc. (“NanoCellect”), the market-leading provider of microfluidic cell sorting solutions to advance cellular discoveries announced

Share on twitter Share on linkedin SAN FRANCISCO, Sept. 15, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics, Inc., the developer of CRISPR-based therapies intended to cure viral infectious diseases, today announced

North America’s foremost environmental services network teams with revolutionary plasma production manufacturer to deliver the only domestically-sourced, premium cathode-grade material from end-of-life batteries

Share on twitter Share on linkedin RIO RANCHO, N.M.–(BUSINESS WIRE)–NTx, a biomanufacturing and bioinformatics company, today announced a collaboration with the University of Notre Dame Department of Computer Science and

Share on twitter Share on linkedin SAN FRANCISCO, Aug. 26, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics Inc, the developer of CRISPR-based therapies intended to cure viral infectious diseases, today announced

Share on twitter Share on linkedin PITTSBURGH, Aug. 17, 2021 (GLOBE NEWSWIRE) — Aspinity, the developer of analog machine learning (analogML™) chips that enable near-zero-power always-on sensing for battery-powered devices,

Share on twitter Share on linkedin SYKESVILLE, Md.–(BUSINESS WIRE)–Zeteo Tech, the biodefense and medical device company that has developed a revolutionary new class of fieldable biological mass spectrometers, has been

The company will leverage the leading intelligent networking platform to transfer and analyze battery information at an unprecedented scale

Share on twitter Share on linkedin SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–InterVenn Biosciences today announced the completion of a $201 million Series C financing. The funding round was led by new

Share on twitter Share on linkedin SAN FRANCISCO, July 29, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics Inc, the developer of CRISPR-based therapies intended to cure viral infectious diseases, today announced

Share on twitter Share on linkedin MINNEAPOLIS–(BUSINESS WIRE)–Niron Magnetics, the company developing the world’s first high performance permanent magnets free of rare earths, today announced it has raised $21.3M in

Share on twitter Share on linkedin SINGAPORE & SAN DIEGO–(BUSINESS WIRE)–ImmunoScape, a biotech company with an immunomics-based technology platform that provides novel insights into the human immune system, today announced

Share on twitter Share on linkedin ALBUQUERQUE, N.M.–(BUSINESS WIRE)–BioFlyte, a biodetection company with a revolutionary new class of fieldable biological threat collection, detection, and identification solutions, today announced the formation

Share on twitter Share on linkedin BOSTON & SAN DIEGO & TAMPA, Fla. & WASHINGTON–(BUSINESS WIRE)–Anzu Partners, an investment firm that focuses on early stage industrial and life science technology

Share on twitter Share on linkedin SAN DIEGO, Calif., (July 6, 2021) — Further expanding its commitment to deliver the benefits of simple, high viability cell sorting solutions globally, NanoCellect

DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb, Inc., today announced the expansion of the company’s leadership team with the appointment of Gary Harton, Ph.D., as Chief Scientific Officer. He has more than 30 years

Share on linkedin Share on twitter CHICAGO, June 29, 2021 (GLOBE NEWSWIRE) — Azumo, a breakthrough display technology company, today announces the appointment of electronics industry veteran Shirley Gu as

SINGAPORE & SAN DIEGO–(BUSINESS WIRE)–ImmunoScape, a biotech company with an immunomics-based technology platform that provides novel insights into the human immune system, today announced it has made three strategic additions

Share on twitter Share on linkedin CANBERRA, Australia and SAN DIEGO, June 23, 2021 (GLOBE NEWSWIRE) — Liquid Instruments, an innovator in precision software-defined instrumentation, today announced Moku:Pro, a high-performance

Share on twitter Share on linkedin SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–InterVenn Biosciences today announced it has completed clinical and analytical validation in compliance with standards set by the Clinical Laboratory

Share on twitter Share on linkedin CAMBRIDGE, Mass.–(BUSINESS WIRE)–Weavr Health (formerly Boston Microfluidics), a diagnostics company, has submitted a request to the U.S. Food and Drug Administration (FDA) for emergency

Share on twitter Share on linkedin WALTHAM, Mass.–(BUSINESS WIRE)–GelSight, a pioneer in industrial tactile imaging and sensing technology, today announced that experienced imaging technology executive Youssef Benmokhtar has joined the

SANTA CLARA, Calif., June 3, 2021 /PRNewswire/ — Based on its recent analysis of the North American battery analytics software-as-a-service (SaaS) market, Frost & Sullivan recognizes Voltaiq, Inc. with the 2021 North

SAN FRANCISCO, May 27, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics (“Excision”), a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives, today announced the addition of infectious

ALBUQUERQUE, N.M.–(BUSINESS WIRE)–BioFlyte, a biodetection company with a new class of fieldable biological threat collection, detection, and identification solutions, today announced the launch of the Sentinel™ Airborne COVID-19 Detection System

SAN FRANCISCO, May 24, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics (“Excision”), a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives, today announced the appointment of biotechnology

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–InterVenn Biosciences today announced Regina Benjamin, MD, MBA, has joined the Company’s Board of Advisors, effective March 25, 2021. Dr. Benjamin joins the InterVenn Board of

SAN DIEGO and CANBERRA, Australia , May 19, 2021 (GLOBE NEWSWIRE) — Today, Liquid Instruments, an innovator in software-defined instrumentation announced it has raised $13.7 million in new financing supported

SAN DIEGO, May 13, 2021 /PRNewswire/ — NanoCellect Biomedical, a leader in the development of cell sorting, announces the virtual launch, scheduled for May 18, 2021, of the WOLF G2 Cell

BERKELEY, Calif., May 12, 2021 /PRNewswire/ — Voltaiq, the leader in Enterprise Battery Intelligence™ (EBI) software, today announced it has made three strategic additions to its team in recent months, including

RIO RANCHO, N.M.–(BUSINESS WIRE)–NTx, biomanufacturing and bioinformatics company, today announced that biopharma industry veteran Nancy Rurkowski has joined its Board of Directors. Rurkowski brings over 35 years of pharmaceutical and

CENTENNIAL, Colo.–(BUSINESS WIRE)–NUBURU, the leader in high power blue laser technology, today announced that it has been awarded U.S. Patent No. 10,971,896 by the U.S. Patent Office. This new patent

SAN FRANCISCO, May 05, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics (“Excision”), a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives, today announced the addition of gene

SAN FRANCISCO, May 03, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics (“Excision”), a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives, today announced the appointment of Christine

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–InterVenn Biosciences today announced that Arnold Levine, Ph.D., has joined the Company’s Board of Advisors, effective March 19, 2021. Dr. Levine joins the InterVenn Board of